Enzymes such as ACLY, ACSS2, and ACC1 are widely upregulated in various cancers, including CRC, underscoring their critical roles in the metabolic hub centered on acetyl‐CoA. The gene discussed is ACSS2; the disease is colorectal carcinoma.